Fig. 4

Maternal CRPs, NLRs, and MLRs increased with the progression of HCA. (A) Maternal CRPs (control group vs. stage 1 vs. stage 2 vs. stage 3, mean ± standard deviation, 8.49 ± 6.32 vs. 13.51 ± 11.35 vs. 14.21 ± 12.90 vs. 14.81 ± 13.91, p < 0.0001) significantly and progressively increased with the progression of acute HCA. (B) NLRs (11.21 ± 5.08 vs. 12.61 ± 5.42 vs. 13.08 ± 5.40 vs. 13.31 ± 6.47, p < 0.0001) significantly and progressively increased with the progression of acute HCA. (C) MLRs (0.56 ± 0.21 vs. 0.69 ± 0.27 vs. 0.69 ± 0.30 vs. 0.74 ± 0.35, p < 0.0001) significantly and progressively increased with the progression of acute HCA. (D) Frequency of increased CRP (≥ 6.90 mg/L) (47.06% vs. 66.67% vs. 68.00% vs. 70.30%, p < 0.0001) significantly and progressively increased with the progression of acute HCA. (E) Frequency of increased NLR (≥ 11.93) (33.16% vs. 45.89% vs. 49.14% vs. 50.76%, p < 0.0001) significantly and progressively increased with the progression of acute HCA. (F) Frequency of increased MLR (≥ 0.57) (43.32% vs. 61.04% vs. 62.86% vs. 68.44%, p < 0.0001) significantly and progressively increased with the progression of acute HCA